The global Bio-active Peptide market is projected to witness substantial growth, increasing from US$ 2,508.3 million in 2023 to US$ 4,191.8 million by 2033, with a notable compound annual growth rate (CAGR) of 5.3% during the projection period.
Key Trends Listed by Future Market Insights (FMI):
In fish processing, a large number of by-products, including bones, heads, skin, and viscera get wasted or downgraded as feed on a regular basis.
These by-products are high in proteins and bioactive nitrogenous compounds, which can be transformed into peptides through bacterial fermentation and enzymatic hydrolysis.
Peptides are physiologically active as they assist in physiological functions in organisms along with increasing applications in the pharmaceutical and food industry.
In the food industry, bioactive peptides are used as antioxidants and preservatives to prevent food spoilage.
Peptides have functional properties which are used in various aspects of food processing, such as solubility, fat-binding, water-holding capacity, and gel-forming
Various research shows that bioactive peptides have valuable applications in the pharmaceutical industry as an antioxidant, anticoagulants, antihypertensives, and immunomodulators. These properties make peptides attractive ingredient for the development of functional foods and nutraceuticals with desirable properties.
In October 2022, a collaborative study conducted by researchers from Hofseth BioCare and Stanford University showed that the bioactive peptides in salmon-derived ProGo promote a healthy balance within the gastrointestinal immune system.
Furthermore, it has been observed that the four most common causes of non-communicable disease (NCD) are cardiovascular diseases, cancer, diabetes, and respiratory diseases.
Marine organisms have been found to be a rich source of bioactive peptides that can help in the prevention and treatment of NCD.
Recent pharmacological research has revealed the anti-cancer benefits of marine-derived bioactive peptides in human breast cancer, cervical cancer, liver cancer, and prostate cancer (PC-3).
As a result, several investigations and research are being conducted to better understand the therapeutic roles of bioactive peptides NCD.
| Attributes | Key Insights |
|---|---|
| Estimated Global Bio-active Peptide Market Size (2023E) | US$ 2,508.3 million |
| Projected Bio-active Peptide Market Value (2033F) | US$ 4,191.8 million |
| Value-based CAGR (2023 to 2033) | 5.3% |
| Top 3 Countries’ Value | US$ 3292.6 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2022 Projected (P) | 4.6% |
| Jul to Dec (H2), 2021 (A) | 4.4% |
| Jul to Dec (H2), 2022 Projected (P) | 5.2% |
| Jan to Jun (H1), 2022 Outlook (O) | 4.2% |
| Jul to Dec (H2), 2022 Outlook (O) | 5.5% |
| BPS Change: H1, 2022 (O) to H1, 2021 (A) | 34 |
| Jan to Jun (H1), 2023 Projected (P) | 4.9% |
| BPS Change: H1, 2022 (O) to H1, 2022 (P) | 39 |
| Jan to Jun (H1), 2021 (A) | 3.9% |
| BPS Change: H2, 2022 (O) to H2, 2022 (P) | -27 |
| BPS Change: H2, 2022 (O) to H2, 2022 (A) | 111 |
At the end of 2022, the global market stood at US$ 2,376.8 million. In the subsequent years, the market achieved a significant growth rate of 5.3%, accounting for US$ 4,191.8 million in 2033.
The global bioactive peptide market experienced significant growth over the years, driven by extensive research and development efforts undertaken by key industry players.
For instance, NeoMatrix Therapeutics, Inc., recently announced promising results from the Phase 1 clinical trial of their bioactive peptide, NMT-cP12.
This peptide is specifically designed for intravenous treatment of burns, with the potential to be administered within 2 to 4 hours of injury.
Furthermore, an increase in the number of inorganic methods such as product launches which were incorporated by the market competitors resulted in the worldwide growth of the bioactive peptide market.
For example, Rousselot, a collagen-based solutions company, announced the launch of Peptan, an MSC-certified (Marine Stewardship Council) marine collagen peptide made from wild-caught marine white fish and certified by the Marine Stewardship Council (MSC).
It was held at Beauty & Skincare Formulation Conference 2021 to help beauty and nutrition brands differentiate and expand their portfolio in nutria-cosmetics and dietary supplements. Such product launches have impacted positively the growth of the bio-active peptide market.
Principal Consultant
Collagen Hydrolysates Market:
| Attributes | Collagen Hydrolysates Market |
|---|---|
| CAGR (2023 to 2033) | 7.2% |
| Market Value (2033) | US$ 1.1 billion |
| Growth Factor | Increasing consumer awareness of health and well-being is driving demand for natural and functional ingredients, which is propelling the market forward. |
| Opportunity | Benefiting from the growing demand for sports nutrition products presents a lucrative opportunity for collagen hydrolysate manufacturers. |
| Key Trends | Trends of Customised and specialized collagen products are becoming popular, allowing companies to cater to specific industry demands. |
Collagen Peptide Market:
| Attributes | Collagen Peptide Market |
|---|---|
| CAGR (2023 to 2033) | 5.7% |
| Market Value (2033) | US$ 1227.24 million |
| Growth Factor | The increase in demand for nutritious products and functional food ingredients during the projection period is both responsible for the market's growth. |
| Opportunity | Opportunities for market expansion are being provided by increasing research and exploration efforts in the search for new Collagen Peptides. |
| Key Trends | Athletes and fitness enthusiasts are incorporating collagen peptide supplements into their regimens, leading to a rise in demand. |
Chitosan Market:
| Attributes | Chitosan Market |
|---|---|
| CAGR (2023 to 2033) | 14.3% |
| Market Value (2033) | US$ 5,112.4 million |
| Growth Factor | Increased demand in the pharmaceutical and biomedical industries for use in drug delivery systems, wound healing, tissue engineering, and other applications. |
| Opportunity | Continued R&D efforts can open up new opportunities to offer improved product formulations and characteristics of chitosan. |
| Key Trends | consumer demand for environmentally friendly products is increasing hence the chitosan market is also experiencing a shift towards more sustainable sourcing. |
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 10.2% |
| Market Value (2033) | US$ 1,509.0 million |
| Region | Europe |
|---|---|
| Country | Germany |
| CAGR | 4.5% |
| Market Value (2033) | US$ 188.6 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 7.8% |
| Market Value (2033) | US$ 1,186.3 million |
| Region | Asia Pacific |
|---|---|
| Country | India |
| CAGR | 9.1% |
| Market Value (2033) | US$ 549.1 million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 6.9% |
| Market Value (2033) | US$ 595.2 million |
Stringent Safety and Regulatory Standards Increased Consumer Trust and Boosted Market
According to FMI analysis, the bio-active peptide market in Germany is expected to grow at a CAGR of 4.5% from 2023 to 2033 to reach a valuation of US$ 188.6 million by 2033.
Germany is known for having stringent quality and safety regulations, especially in the food and pharmaceutical industries.
Consumers value the safety and efficacy of bioactive peptide products that meet these stringent standards. This has raised consumer trust and boosted sales of bioactive peptides in Germany.
Besides its regulation, Germany is home to leading pharmaceutical and nutraceutical companies that are constantly differentiating their product offering to stay competitive in the market.
For instance, BASF launched Peptide 4.0, an inflammatory product that is a rice-derived peptide, it is further aiming to launch two more products, PeptiYouth and PeptiStrong, derived from peas and fava beans.
Consistent Research Helping to Discover Various Sources of Bioactive Peptides in the United States
The demand for bioactive peptides in the United States is expected to grow at a CAGR of 10.2% during the forecast period 2023 to 2033, reaching a market size of US$ 1,509.0 million by the end of 2033
Ongoing research and development projects in the field of bioactive peptides have resulted in the discovery of peptide sources, improved extraction methods, and enhanced understanding of their bioactivity.
This has led to the development of new ingredients with improved efficacy and safety in the United States.
For instance, Lunacin, a bioactive peptide, is being developed that occurs naturally in soybeans and other plant-based foods.
Over the years, scientists worked on the extraction and purification processes of Lunacin from bioactive sources in a concentrated and standardized form.
This breakthrough helped manufacturers in the United States to incorporate Lunacin in numerous food and dietary supplement products.
Increased adoption of natural, sustainable, and minimally invasive technology driving the market in India.
Bio-active Peptide demand in India is anticipated to grow at a CAGR of 9.1% during the forecast period from 2023 to 2033 to hold a market size of US$ 549.1 million by the end of 2033.
Consumers in India are very much attracted to minimally invasive technologies that give preference to sustainability, quality, efficiency, and safety.
As these technologies continue to develop with minimal environmental damage, they will continue to become more widely adopted in India and hence resulting in the production of bioactive peptide-based products.
Besides this, factors such as growing health and wellness awareness, demand for natural and functional ingredients, India's traditional medical legacy, and an emphasis on preventative healthcare play important roles in the increased acceptance of bioactive peptides in the Indian market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Hypoallergenic Nature of Plant-Based Bioactive Peptides Drives Demand as An Alternative to Animal-Based Peptides.
Based on the source, demand for plant-based bioactive peptides is expected to continue as it is holding a market share of 34.0% to reach a market valuation of US$ 1,425.0 million by the end of 2033.
It is observed that some individuals are allergic to animal-based peptides such as those generated from dairy or shellfish in such cases plant-based peptides cater to the need of these consumers.
Plant-based peptides provide a hypoallergenic alternative and are widely available at retail stores and are more appealing to this segment of the consumer.
Besides this, there are few countries that have stricter restrictions and ethical norms regarding animal-based products which hampers the production and marketing of animal-derived bioactive peptides.
Here as well, plant-derived bioactive peptides act as an alternative solution to fulfill the demand.
Easy Digestibility and Bioavailability of Milk-Derived Bioactive Peptides Peptide Benefiting the Market
According to FMI analysis, the milk bioactive peptides segment is predicted to attain a market share of 35.2% during the assessment period, resulting in a market size of US$ 1,467.1 million by 2033.
Industrial-scale processes are already established for extracting biologically active, nondenatured, whey proteins as a direct byproduct of cheese production. Similarly, caseins are produced on a huge scale for culinary products such as cottage cheese.
As a result, salvaging these protein fractions and generating active peptides from them is economically feasible to use as safe and effective natural preservatives, dietary supplements, and milk-based nutraceuticals.
On the other hand, milk proteins, from which milk peptides are derived, are highly digestible and bioavailable due to which the demand for milk bioactive peptides is increasing during the forecast period.
The Presence of Various Health Claims Led to The Establishment of Customer Trust, Which Fuelled the Popularity of Dietary Supplements
According to FMI, the use of Bio-active Peptides in dietary supplements is growing, and it is expected to have a market share of 32.0% and a market size of US$ 1,341.3 million by the end of 2033.
Dietary supplements enable the incorporation of health claims and marketing messages emphasizing the specific benefits of bioactive peptides.
This allows manufacturers to target specific health issues or illnesses, such as cardiovascular health, immunological support, or cognitive function.
Furthermore, in comparison to pharmaceuticals and animal feed, the ease of availability, consumer inclination for preventative healthcare, marketing opportunities, and regulatory considerations favor the use of bioactive peptides in dietary supplements.
However, bioactive peptides are still being researched, and their application in various industries, including pharmaceuticals and animal feeding is under process considering their medicinal and performance-enhancing properties.
The Bio-active Peptide market has a diverse and dynamic competitive landscape. To serve industries such as food and drinks, pharmaceuticals, and supplements, leading companies specializing in diverse fields are focusing on research and development, sustainable sourcing, and new formulations.
These companies emphasize environmentally friendly practices, product certifications, and satisfying the increased demand for natural and sustainable ingredients. Additionally, it tries to preserve its market position and capitalize on the growing demand by focusing on quality, innovation, and matching customer preferences.
For instance:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | US$ 2,508.3 million |
| Market Forecast Value in 2033 | US$ 4,191.8 million |
| Anticipated Growth Rate (2023 to 2033) | 5.3% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (US$ Million) |
| Key Regions Covered | Latin America; Europe; South Asia; North America; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | United States, Thailand, Mexico, Canada, Indonesia, Chile, Brazil, Peru, Argentina, France, Germany, Spain, Italy, Netherlands, Nordic, Belgium, United Kingdom, Russia, Poland, South Korea, China, Japan, Australia, India, Malaysia, Singapore, New Zealand, GCC Countries, South Africa, Central Africa, and others |
| Key Market Segments Covered | Type, Source, Form, Application, and Region |
| Key Companies Profiled | Angel Yeast Co., Ltd.; BASF SE; Seagarden AS; Archer Daniels Midland Company; Ingredia SA; Rousselot S.A.S.; FrieslandCampina Ingredients; Peptan; Kerry Group plc; CP Kelco USA, Inc.; Others (on additional request) |
The bio-active peptide market is valued at US$ 2,508.3 million in 2023.
The market is projected to experience a 5.3% CAGR until 2033.
The market is estimated to be worth US$ 4,191.8 million in 2033.
India is anticipated to develop at a CAGR of 9.1% from 2023 to 2033.
Peptan, Kerry Group plc and, CP Kelco USA, Inc. are the key market players.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Forecast Factors - Relevance & Impact 3.6. Regulations and Policies 4. Global Market - Pricing Analysis 4.1. Price Point Assessment by Region 4.1.1. Manufacturer-Level Pricing 4.1.2. Distributor Level Pricing 4.2. Price Point Assessment By Source 4.3. Price Forecast till 2033 5. Value Chain Analysis 5.1. Operating margins at each node of the supply chain 5.2. List of Active Market Participants 6. Global Market Size (in Value (US$ Million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis, 2018 to 2022 6.2. Current and Future Market Size (in Value (US$ Million) and Volume (MT) Analysis, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 7.1. Introduction / Key Findings 7.2. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis By Source, 2018 to 2022 7.3. Current and Future Market Size (in Value (US$ Million) and Volume (MT) Analysis and Forecast By Source, 2023 to 2033 7.3.1. Plant 7.3.2. Animal 7.3.3. Marine 7.4. Market Attractiveness Analysis By Source 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis By Type, 2018 to 2022 8.3. Current and Future Market Size (in Value (US$ Million) and Volume (MT) Analysis and Forecast By Type, 2023 to 2033 8.3.1. Milk Peptides 8.3.2. Egg Peptides 8.3.3. Soy Peptides 8.3.4. Marine Peptides 8.3.5. Meat Peptides 8.3.6. Others 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis By Application, 2018 to 2022 9.3. Current and Future Market Size (in Value (US$ Million) and Volume (MT) Analysis and Forecast By Application, 2023 to 2033 9.3.1. Functional Food 9.3.2. Dietary Supplements 9.3.3. Pharmaceuticals 9.3.4. Animal Feed 9.3.5. Others 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Form 10.1. Introduction / Key Findings 10.2. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis By Form, 2018 to 2022 10.3. Current and Future Market Size (in Value (US$ Million) and Volume (MT) Analysis and Forecast By Form, 2023 to 2033 10.3.1. Liquid 10.3.2. Powder 10.3.3. Capsule 10.4. Market Attractiveness Analysis By Form 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 11.1. Introduction 11.2. Historical Market Size (in Value (US$ Million) and Volume (MT) Analysis By Region, 2018 to 2022 11.3. Current Market Size (in Value (US$ Million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East & Africa 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 12.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 12.4.1. By Country 12.4.1.1. USA 12.4.1.2. Canada 12.4.2. By Source 12.4.3. By Type 12.4.4. By Application 12.4.5. By Form 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Source 12.5.3. By Type 12.5.4. By Application 12.5.5. By Form 12.6. Key Takeaways 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Colombia 13.4.1.4. Argentina 13.4.1.5. Rest of Latin America Bio-active Peptide 13.4.2. By Source 13.4.3. By Type 13.4.4. By Application 13.4.5. By Form 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Source 13.5.3. By Type 13.5.4. By Application 13.5.5. By Form 13.6. Key Takeaways 14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. UK 14.4.1.3. France 14.4.1.4. Italy 14.4.1.5. Spain 14.4.1.6. BENELUX 14.4.1.7. Nordic 14.4.1.8. Russia 14.4.1.9. Poland 14.4.1.10. Rest of Europe 14.4.2. By Source 14.4.3. By Type 14.4.4. By Application 14.4.5. By Form 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Source 14.5.3. By Type 14.5.4. By Application 14.5.5. By Form 14.6. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.2. By Source 15.4.3. By Type 15.4.4. By Application 15.4.5. By Form 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Source 15.5.3. By Type 15.5.4. By Application 15.5.5. By Form 15.6. Key Takeaways 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 16.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. India 16.4.1.2. Thailand 16.4.1.3. Malaysia 16.4.1.4. Indonesia 16.4.1.5. Singapore 16.4.1.6. Rest of South Asia Bio-active Peptide 16.4.2. By Source 16.4.3. By Type 16.4.4. By Application 16.4.5. By Form 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Source 16.5.3. By Type 16.5.4. By Application 16.5.5. By Form 16.6. Key Takeaways 17. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 17.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 17.4.1. By Country 17.4.1.1. Australia 17.4.1.2. New Zealand 17.4.2. By Source 17.4.3. By Type 17.4.4. By Application 17.4.5. By Form 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Source 17.5.3. By Type 17.5.4. By Application 17.5.5. By Form 17.6. Key Takeaways 18. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 18.4. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2023 to 2033 18.4.1. By Country 18.4.1.1. UAE 18.4.1.2. Saudi Arabia 18.4.1.3. Other GCC Countries 18.4.1.4. North Africa 18.4.1.5. South Africa 18.4.1.6. Central Africa 18.4.2. By Source 18.4.3. By Type 18.4.4. By Application 18.4.5. By Form 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Source 18.5.3. By Type 18.5.4. By Application 18.5.5. By Form 18.6. Key Takeaways 19. Country-level Market Analysis 19.1. US Market Analysis 19.1.1. By Source 19.1.2. By Type 19.1.3. By Application 19.1.4. By Form 19.2. Canada Market Analysis 19.2.1. By Source 19.2.2. By Type 19.2.3. By Application 19.2.4. By Form 19.3. Brazil Market Analysis 19.3.1. By Source 19.3.2. By Type 19.3.3. By Application 19.3.4. By Form 19.4. Mexico Market Analysis 19.4.1. By Source 19.4.2. By Type 19.4.3. By Application 19.4.4. By Form 19.5. Argentina Market Analysis 19.5.1. By Source 19.5.2. By Type 19.5.3. By Application 19.5.4. By Form 19.6. Germany Market Analysis 19.6.1. By Source 19.6.2. By Type 19.6.3. By Application 19.6.4. By Form 19.7. UK Market Analysis 19.7.1. By Source 19.7.2. By Type 19.7.3. By Application 19.7.4. By Form 19.8. France Market Analysis 19.8.1. By Source 19.8.2. By Type 19.8.3. By Application 19.8.4. By Form 19.9. Italy Market Analysis 19.9.1. By Source 19.9.2. By Type 19.9.3. By Application 19.9.4. By Price Range 19.9.5. By Form 19.10. Spain Market Analysis 19.10.1. By Source 19.10.2. By Type 19.10.3. By Application 19.10.4. By Form 19.11. BENELUX Market Analysis 19.11.1. By Source 19.11.2. By Type 19.11.3. By Application 19.11.4. By Form 19.12. Nordic Market Analysis 19.12.1. By Source 19.12.2. By Type 19.12.3. By Application 19.12.4. By Form 19.13. Russia Market Analysis 19.13.1. By Source 19.13.2. By Type 19.13.3. By Application 19.13.4. By Form 19.14. Poland Market Analysis 19.14.1. By Source 19.14.2. By Type 19.14.3. By Application 19.14.4. By Form 19.15. China Market Analysis 19.15.1. By Source 19.15.2. By Type 19.15.3. By Application 19.15.4. By Form 19.16. Japan Market Analysis 19.16.1. By Source 19.16.2. By Type 19.16.3. By Application 19.16.4. By Form 19.17. South Korea Market Analysis 19.17.1. By Source 19.17.2. By Type 19.17.3. By Application 19.17.4. By Form 19.18. India Market Analysis 19.18.1. By Source 19.18.2. By Type 19.18.3. By Application 19.18.4. By Form 19.19. Thailand Market Analysis 19.19.1. By Source 19.19.2. By Type 19.19.3. By Application 19.19.4. By Form 19.20. Malaysia Market Analysis 19.20.1. By Source 19.20.2. By Type 19.20.3. By Application 19.20.4. By Form 19.21. Indonesia Market Analysis 19.21.1. By Source 19.21.2. By Type 19.21.3. By Application 19.21.4. By Form 19.22. Vietnam Market Analysis 19.22.1. By Source 19.22.2. By Type 19.22.3. By Application 19.22.4. By Form 19.23. Philippines Market Analysis 19.23.1. By Source 19.23.2. By Type 19.23.3. By Application 19.23.4. By Form 19.24. Singapore Market Analysis 19.24.1. By Source 19.24.2. By Type 19.24.3. By Application 19.24.4. By Form 19.25. Australia Market Analysis 19.25.1. By Source 19.25.2. By Type 19.25.3. By Application 19.25.4. By Form 19.26. New Zealand Market Analysis 19.26.1. By Source 19.26.2. By Type 19.26.3. By Application 19.26.4. By Form 19.27. Turkey Market Analysis 19.27.1. By Source 19.27.2. By Type 19.27.3. By Application 19.27.4. By Form 19.28. Egypt Market Analysis 19.28.1. By Source 19.28.2. By Type 19.28.3. By Application 19.28.4. By Form 19.29. South Africa Market Analysis 19.29.1. By Source 19.29.2. By Type 19.29.3. By Application 19.29.4. By Form 19.30. GCC Countries Market Analysis 19.30.1. By Source 19.30.2. By Type 19.30.3. By Application 19.30.4. By Form 20. Market Structure Analysis 20.1. Global Market Competition - a Dashboard View 20.2. Industry Structure Analysis 20.2.1. % tier 1 market players 20.2.2. % tier 2 market players 20.2.3. % tier 3 market players 20.3. Global Market Company Share Analysis 20.3.1. For Tier 1 Market Players, 2022 20.3.2. Company Market Share Analysis of Top 5 Players, By Region 20.4. Key Participants Market Presence (Intensity Mapping) by Region 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. BASF SE 21.3.1.1. Product Portfolio 21.3.1.2. Type 21.3.1.3. Revenue by Market Segments (Product/Channel/Region) 21.3.1.4. Sales Footprint 21.3.1.5. Strategy Overview 21.3.1.5.1. Marketing Strategy 21.3.1.5.2. Product Strategy 21.3.1.5.3. Channel Strategy 21.3.1.6. SWOT Analysis 21.3.2. Angel Yeast Co., Ltd. 21.3.2.1. Product Portfolio 21.3.2.2. Type 21.3.2.3. Revenue by Market Segments (Product/Channel/Region) 21.3.2.4. Sales Footprint 21.3.2.5. Strategy Overview 21.3.2.5.1. Marketing Strategy 21.3.2.5.2. Product Strategy 21.3.2.5.3. Channel Strategy 21.3.2.6. SWOT Analysis 21.3.3. Seagarden AS 21.3.3.1. Product Portfolio 21.3.3.2. Type 21.3.3.3. Revenue by Market Segments (Product/Channel/Region) 21.3.3.4. Sales Footprint 21.3.3.5. Strategy Overview 21.3.3.5.1. Marketing Strategy 21.3.3.5.2. Product Strategy 21.3.3.5.3. Channel Strategy 21.3.3.6. SWOT Analysis 21.3.4. Archer Daniels Midland Company 21.3.4.1. Product Portfolio 21.3.4.2. Type 21.3.4.3. Revenue by Market Segments (Product/Channel/Region) 21.3.4.4. Sales Footprint 21.3.4.5. Strategy Overview 21.3.4.5.1. Marketing Strategy 21.3.4.5.2. Product Strategy 21.3.4.5.3. Channel Strategy 21.3.4.6. SWOT Analysis 21.3.5. Ingredia SA 21.3.5.1. Product Portfolio 21.3.5.2. Type 21.3.5.3. Revenue by Market Segments (Product/Channel/Region) 21.3.5.4. Sales Footprint 21.3.5.5. Strategy Overview 21.3.5.5.1. Marketing Strategy 21.3.5.5.2. Product Strategy 21.3.5.5.3. Channel Strategy 21.3.5.6. SWOT Analysis 21.3.6. Rousselot S.A.S. 21.3.6.1. Product Portfolio 21.3.6.2. Type 21.3.6.3. Revenue by Market Segments (Product/Channel/Region) 21.3.6.4. Sales Footprint 21.3.6.5. Strategy Overview 21.3.6.5.1. Marketing Strategy 21.3.6.5.2. Product Strategy 21.3.6.5.3. Channel Strategy 21.3.6.6. SWOT Analysis 21.3.7. FrieslandCampina Ingredients 21.3.7.1. Product Portfolio 21.3.7.2. Type 21.3.7.3. Revenue by Market Segments (Product/Channel/Region) 21.3.7.4. Sales Footprint 21.3.7.5. Strategy Overview 21.3.7.5.1. Marketing Strategy 21.3.7.5.2. Product Strategy 21.3.7.5.3. Channel Strategy 21.3.7.6. SWOT Analysis 21.3.8. Peptan 21.3.8.1. Product Portfolio 21.3.8.2. Type 21.3.8.3. Revenue by Market Segments (Product/Channel/Region) 21.3.8.4. Sales Footprint 21.3.8.5. Strategy Overview 21.3.8.5.1. Marketing Strategy 21.3.8.5.2. Product Strategy 21.3.8.5.3. Channel Strategy 21.3.8.6. SWOT Analysis 21.3.9. Kerry Group plc 21.3.9.1. Product Portfolio 21.3.9.2. Type 21.3.9.3. Revenue by Market Segments (Product/Channel/Region) 21.3.9.4. Sales Footprint 21.3.9.5. Strategy Overview 21.3.9.5.1. Marketing Strategy 21.3.9.5.2. Product Strategy 21.3.9.5.3. Channel Strategy 21.3.9.6. SWOT Analysis 21.3.10. CP Kelco USA, Inc. 21.3.10.1. Product Portfolio 21.3.10.2. Type 21.3.10.3. Revenue by Market Segments (Product/Channel/Region) 21.3.10.4. Sales Footprint 21.3.10.5. Strategy Overview 21.3.10.5.1. Marketing Strategy 21.3.10.5.2. Product Strategy 21.3.10.5.3. Channel Strategy 21.3.10.6. SWOT Analysis 21.3.11. Other Players (On Additional Requests) 21.3.11.1. Product Portfolio 21.3.11.2. Type 21.3.11.3. Revenue by Market Segments (Product/Channel/Region) 21.3.11.4. Sales Footprint 21.3.11.5. Strategy Overview 21.3.11.5.1. Marketing Strategy 21.3.11.5.2. Product Strategy 21.3.11.5.3. Channel Strategy 21.3.11.6. SWOT Analysis 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Food and Beverage Insights
View Reports
Bio-active Peptide Market
